Table 1.
Study | Mean utility obtained using the value set from
|
|||
---|---|---|---|---|
United Kingdom | the Netherlands | Germany | Spain | |
General population23 | 0.8299 | 0.8547 | 0.8963 | 0.8619 |
Human immunodeficiency virus20 | 0.8525 | 0.8606 | 0.9206 | 0.8827 |
Cardiovascular disease19 | 0.6460 | 0.7070 | 0.7664 | 0.6537 |
Case-management in chronic obstructive pulmonary disease24 | 0.6457 | 0.6916 | 0.7710 | 0.6607 |
Telehealthcare in chronic obstructive pulmonary disease21 | 0.6478 | 0.7031 | 0.7666 | 0.6571 |
Allergy patients on a day without symptoms22 | 0.9778 | 0.9794 | 0.9917 | 0.9866 |
Allergy patients on a day with symptoms22 | 0.7324 | 0.7791 | 0.8329 | 0.7641 |